On Monday, Solventum stock received a positive adjustment to its Relative Strength (RS) Rating, from 66 to 74.
Can You Really Time The Stock Market?
IBD's unique rating identifies price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 as they begin their largest price moves. See if Solventum stock can continue to rebound and clear that threshold.
Is Solventum Stock A Buy?
Solventum stock is trying to complete a consolidation with an 85.92 entry. See if the medical stock can clear the breakout price in heavy trade.
Earnings growth slowed in the most recent quarter from -35% to -36%. But revenue moved higher, from 2% to 3%.
Solventum stock earns the No. 37 rank among its peers in the Medical-Products industry group. Boston Scientific, Insulet and LifeMD are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
